Wash. The O Pastel aquatic center should reopen on Monday

the essential For several months, the community of municipalities Tarn-Agout (CCTA) has been faced with recurring technical problems which disrupt the operation of the inter-municipal aquatic center. The opening of the O Pastel is often “dotted” with many closing periods. The site is currently closed to the public until Sunday, May 21 inclusive. These “technical … Read more

Одобрена рекомбинантная мультивалентная белковая вакцина против COVID-19 от вариантов XBB USA – Pусский USA – English USA – English Brazil – Português USA – Deutsch Latin America – español

Первая в своем роде: рекомбинантная мультивалентная белковая вакцина против COVID-19 от вариантов XBB производства WestVac Biopharma/Западно-китайского медицинского центра Сычуаньского университета была одобрена для клинических испытаний Национальным управлением медицинской продукции Китая. ЧЭНДУ, Китай, 19 мая 2023 г. /PRNewswire/ — 17 мая 2023 года рекомбинантная двухвалентная белковая вакцина против COVID-19 (клетки Sf9) и рекомбинантная трехвалентная тримерная белковая … Read more

Der rekombinante multivalente COVID-19-Protein-Impfstoff gegen XBB-Varianten von WestVac Biopharma/West China Medical Center, Sichuan University wurde für klinische Versuche zugelassen.

CHENGDU, China, 19. Mai 2023 /PRNewswire/ — Am 17. Mai 2023 erhielten der rekombinante bivalente COVID-19-Protein-Impfstoff (Sf9-Zellen) und der rekombinante trivalente COVID-19-Protein-Impfstoff (Sf9-Zellen), die von WestVac Biopharma/ West China Medical Center, Sichuan University gegen die neuesten zirkulierenden XBB-Varianten entwickelt wurden, die “Genehmigung für klinische Versuche” von der National Medical Products Administration of China. Diese beiden … Read more

la vacuna proteica contra la COVID-19 multivalente recombinante contra las variantes XBB de WestVac Biopharma/Centro Médico de China Occidental, Sichuan University, se aprobó para ensayos clínicos por la NMPA.

CHENGDU, China, 18 de mayo de 2023 /PRNewswire/ — El 17 de mayo de 2023, la vacuna proteica bivalente recombinante contra la COVID-19 (células Sf9) y la vacuna proteica trivalente recombinante contra la COVID-19 (células Sf9) desarrolladas por WestVac Biopharma/Centro Médico de China Occidental, Sichuan University, contra las variantes XBB más recientes, recibieron la “aprobación … Read more

Primeira vacina recombinante multivalente de proteína COVID-19 no mundo contra variantes XBB pela Biopharma/West China Medical Center (Universidade de Sichuan) aprovada para estudos clínicos pela Administração Nacional de Produtos Médicos da China. USA – English USA – English Israel – English India – English Brazil – Português

CHENGDU, China, 18 de maio de 2023 /PRNewswire/ — Em 17 de maio de 2023, a vacina bivalente de proteína COVID-19 recombinante (células Sf9) e a vacina trivalente de proteína trímera COVID-19 recombinante (células Sf9) desenvolvidas pela WestVac Biopharma/West China Medical Center, da Universidade de Sichuan, contra as variantes XBB mais recentes em circulação, receberam … Read more

DocuSign Announces Timing of First Quarter Fiscal 2024 Earnings Conference Call

SAN FRANCISCO, May 18, 2023 /PRNewswire/ — DocuSign (Nasdaq: DOCU) today announced that its first quarter fiscal 2024 results will be released on Thursday, June 8, 2023, after the close of the market. The company will host a conference call at 1:30 p.m. Pacific Standard Time (4:30 p.m. Eastern Standard Time) to discuss its financial results. A live webcast of the event will … Read more

Dr. Linda Tolbert selected as executive medical director for the Washington Permanente Medical Group

Kaiser Permanente health care leader, educator, innovator, and culture change champion leads one of the state’s largest multispecialty medical groups SEATTLE, May 18, 2023 /PRNewswire/ — A new era has launched for the Washington Permanente Medical Group (WPMG), with the selection of its new executive medical director, Linda Tolbert, MD, JD, EdD, MPH, who officially … Read more